⏳ Fetching live dividend data...
Home › Calculator › NTLA Dividend Calculator 2026
Intellia Therapeutics, Inc. · NASDAQ
Price: $14.07 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in NTLA → $75.08M in 10 years · $5,989,137.14/month
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemophilia A and hemophilia B, hyperoxaluria Type 1, and alpha-1 antitrypsin deficiency. Its ex vivo pipeline includes NTLA-5001 for the treatment of acute myeloid leukemia; and proprietary programs focused on developing engineered cell therapies to treat various oncological and autoimmune disorders. In addition, it offers tools comprising of Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system. Intellia Therapeutics, Inc. has license and collaboration agreements with Novartis Institutes for BioMedical Research, Inc. to engineer hematopoietic stem cells for the treatment of sickle cell disease; Regeneron Pharmaceuticals, Inc. to co-develop potential products for the treatment of hemophilia A and hemophilia B; Ospedale San Raffaele; and a strategic collaboration with SparingVision SAS to develop novel genomic medicines utilizing CRISPR/Cas9 technology for the treatment of ocular diseases. The company was formerly known as AZRN, Inc. Intellia Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open NTLA position with:
Real after-tax yield depends on where you live and how you hold NTLA.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 14.21% | 11.41% | $1,421 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 12.08% | 9.28% | $1,208 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 11.37% | 8.57% | $1,137 / yr |
| 🇬🇧 UK ISA | 0% | 14.21% | 11.41% | $1,421 / yr |
| 🇬🇧 UK Taxable | 8.75% | 12.97% | 10.17% | $1,297 / yr |
| 🇨🇦 TFSA | 0% | 14.21% | 11.41% | $1,421 / yr |
| 🇨🇦 CA Taxable | 25% | 10.66% | 7.86% | $1,066 / yr |
| 🇦🇺 Super (pension) | 15% | 12.08% | 9.28% | $1,208 / yr |
| 🇦🇺 AU Taxable | 30% | 9.95% | 7.15% | $995 / yr |
| 🇩🇪 DE Taxable | 26.375% | 10.46% | 7.66% | $1,046 / yr |
| 🇫🇷 FR Taxable | 30% | 9.95% | 7.15% | $995 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
NTLA pays quarterly — 4 times per year. Next ex-div: TBD.
How NTLA compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for NTLA sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-03-01 | 156,400 | — | — | ||
| A-Award | 2026-03-01 | 225,400 | $13.78 | $3.11M | ||
| A-Award | 2026-03-01 | 46,080 | — | — | ||
| Sale | 2026-03-02 | 1,211 | $13.78 | $16.7K | ||
| A-Award | 2026-03-01 | 65,829 | $13.78 | $907.1K | ||
| A-Award | 2026-03-01 | 9,943 | — | — | ||
| A-Award | 2026-03-01 | 14,204 | $13.78 | $195.7K | ||
| A-Award | 2026-03-01 | 61,280 | — | — | ||
| A-Award | 2026-03-01 | 87,543 | $13.78 | $1.21M | ||
| A-Award | 2026-03-01 | 39,200 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the NTLA dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →